Kohl's Corporation vs 22nd Century Group Inc — how do they compare? Kohl's Corporation trades at $19.24 (market cap $2.10B), while 22nd Century Group Inc trades at $4.21 (market cap $1.52M). The key difference: Kohl's Corporation is far larger — about 1381.6× 22nd Century Group Inc's market cap, and Kohl's Corporation pays a 2.7% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| KSS | XXII | |
|---|---|---|
Market Cap | $2.10B | $1.52M |
Sector | Consumer Cyclical | Technology |
52-Week High | $24.71 | $801.00 |
52-Week Low | $11.72 | $3.72 |
Enterprise Value | $8.20B | -$6.71M |
Dividend Yield | 2.7% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →